HEINEKEN NV : Global Fund and HEINEKEN Enter Into Partnership to Fight Against Infectious Diseases in Africa
26 Gennaio 2018 - 11:52AM
YASTEST
Davos, 26 January 2018 - The Global
Fund and HEINEKEN today launched a new partnership, joining forces
to further advance a common goal: ending HIV, tuberculosis and
malaria as epidemics in Africa.
As part of the partnership, HEINEKEN will lend its
expertise in the areas of logistics and communications to support
the Global Fund in better reaching specific demographic groups that
are most at risk of HIV, tuberculosis and malaria.
At the core of the partnership, HEINEKEN will pair
supply chain experts with logistics planners at the Global Fund to
share expertise in demand-forecasting and quality control during
shipment. Locally, HEINEKEN will support efforts in countries in
Africa where the company is present to improve the effectiveness of
the "last mile" distribution, which focuses on ensuring the proper
materials can reach health care facilities and patients in remote
areas. This is presently already taking place in DRC, South Africa
and Nigeria.
Through a series of workshops and creative
support, HEINEKEN marketers will also provide communications
services to the Global Fund to ensure they are reaching the right
audience, with the right message at the right time.
"The Global Fund is a strong believer in the power
of public-private partnerships in order to accelerate progress,"
said Peter Sands, incoming Executive Director of the Global Fund.
"We are particularly excited to leverage the expertise of HEINEKEN
as we develop innovative tools and approaches that will promote HIV
prevention and behaviour change. We also look forward to sharpening
our logistics planning skills to better support our implementing
partners' efforts to deliver health services and commodities
wherever they are needed. These two efforts are vital to improving
health and well-being in Africa."
"HEINEKEN has been present in Africa for over 100
years, and saw first-hand the severity of the AIDS epidemic on
communities. We provided employees with voluntary testing for HIV
and treatment for HIV, tuberculosis and malaria among others from
the start," said Jean-François van Boxmeer, CEO and Chairman of the
Executive Board of HEINEKEN. "We continue to do this today and
recognize there is still a lot to do. Evolving our partnership with
the Global Fund will allow us to work together in order to end
these epidemics in Africa. We greatly respect the work the Global
Fund supports, and we look forward to extending our
partnership."
HEINEKEN is currently a member of the Private
Sector Delegation to the Board of the Global Fund. HEINEKEN medical
doctors have been involved in the Country Coordinating Mechanisms
that direct the Global Fund financing of country programs in DRC
and Burundi. The new partnership will expand the geographical scope
of activities.
- ENDS -
Editorial
information:
For more information, please
contact:
Dayna Adelman -
Dayna.Adelman@heineken.com
Gretchen Lyons -
Gretchen.Lyons@theglobalfund.org
About
HEINEKEN:
HEINEKEN is the world's most
international brewer. It is the leading developer and marketer of
premium beer and cider brands. Led by the Heineken® brand, the
Group has a portfolio of more than 250 international, regional,
local and speciality beers and ciders. We are committed to
innovation, long-term brand investment, disciplined sales execution
and focused cost management. Through "Brewing a Better World",
sustainability is embedded in the business and delivers value for
all stakeholders. HEINEKEN has a well-balanced geographic footprint
with leadership positions in both developed and developing markets.
We employ over 80,000 employees and operate breweries, malteries,
cider plants and other production facilities in more than 70
countries. Heineken N.V. and Heineken Holding N.V. shares trade on
the Euronext in Amsterdam. Prices for the ordinary shares may be
accessed on Bloomberg under the symbols HEIA NA and HEIO NA and on
Reuters under HEIN.AS and HEIO.AS. HEINEKEN has two sponsored level
1 American Depositary Receipt (ADR) programmes: Heineken N.V.
(OTCQX: HEINY) and Heineken Holding N.V. (OTCQX: HKHHY). Most
recent information is available on HEINEKEN's website:
www.theHEINEKENcompany.com and follow us on Twitter via
@HEINEKENCorp.
About the Global Fund to Fight
AIDS, Tuberculosis and Malaria:
The Global Fund is a 21st-century partnership
designed to accelerate the end of AIDS, tuberculosis and malaria as
epidemics. As a partnership between governments, civil society, the
private sector and people affected by the diseases, the Global Fund
mobilizes and invests nearly US$4 billion a year to support
programs run by local experts in more than 100 countries. By
challenging barriers and embracing innovative approaches, we are
working together to better serve people affected by the
diseases.
Global Fund HEINEKEN Press Release
26 January 2018
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: HEINEKEN NV via Globenewswire
Grafico Azioni Heineken (EU:HEIA)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Heineken (EU:HEIA)
Storico
Da Mar 2023 a Mar 2024